Princeton University is about to administer the first doses of a vaccine against meningitis.
A meningitis vaccine not yet licensed for use in the U.S. will be made available at Princeton University beginning Dec. 9.
A female graduate student developed meningitis symptoms on Wednesday and was hospitalized on Thursday.
Federal health officials have agreed to import a meningitis vaccine approved in Europe and Australia but not the U.S. as officials at Princeton University consider measures to stop the spread of the disease on the Ivy League campus.
The health concerns on the Princeton University campus are growing. Another student was diagnosed with meningitis this week, the seventh since March.